4th Quarter - Report
LINCOLN POLICY GROUP for PFIZER
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN ELLING | — |
| BLANCHE LINCOLN | — |
| COLIN ROSKEY New | Health Policy Advisor and Counsel, Senate Finance Committee |
| THOMAS A SCULLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.